COUR Pharma is a startup based in the United States, 1 tracked investor.
COUR Pharma is a company headquartered in the United States. Brouky records 1 investor associated with the company.
COUR Pharma develops targeted antigen-specific therapies aimed at reprogramming the immune system to treat autoimmune diseases such as Type 1 Diabetes and Myasthenia Gravis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.